دورية أكاديمية
Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
| العنوان: | Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model |
|---|---|
| المؤلفون: | Willemin, Marie-EmilieAff1, IDs11523024010936_cor1, Gong, Jue, Hilder, Brandi W., Masterson, Tara, Tolbert, Jaszianne, Renaud, Thomas, Heuck, Christoph, Kane, Colleen, De Zwart, Loeckie, Girgis, Suzette, Ma, Xuewen, Ouellet, Daniele |
| المصدر: | Targeted Oncology. :1-15 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 17762596 1776260X |
|---|---|
| DOI: | 10.1007/s11523-024-01093-6 |